Skip to content
Screener

bioAffinity Technologies, Inc. BIAF Q3 2025 earnings

Reported November 14, 2025 · Before market open

Revenue$1.4MBeat by $35.1K
EPS-$2.70In line
Revenue estimate$1.4M
EPS estimate-$2.70

Next report

Nov 18, 2026 (in 2 months)
Revenue estimate$1.9M
EPS estimate-$31.50

FAQ

When did bioAffinity Technologies, Inc. report Q3 2025 earnings?
bioAffinity Technologies, Inc. (BIAF) reported Q3 2025 earnings on November 14, 2025 before market open.
What were bioAffinity Technologies, Inc.'s Q3 2025 revenue and EPS?
bioAffinity Technologies, Inc. reported revenue of $1.4M and eps of $-2.70 for Q3 2025.
Did bioAffinity Technologies, Inc. beat estimates in Q3 2025?
Revenue beat the consensus estimate of $1.4M by $35.1K. EPS beat the consensus estimate of $-2.70 by $0.00.
How did bioAffinity Technologies, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 38.5% from $2.4M a year earlier and eps declined 1587.5% from $-0.16.
Where can I find bioAffinity Technologies, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-022604) and the 10-Q periodic report (0001493152-25-023405) directly on SEC EDGAR. The filing index links above go to sec.gov.